1227
One week after the initial-dose of adalimumab (160 mg), which was initiated due to an acute exacerbation of Crohn's disease, the patient developed a fulminant cardiomyopathy.
 ( adverse event: developed ,  an acute exacerbation of Crohn's disease, the patient: Subject, fulminant cardiomyopathy: Effect, One week after the initial-dose of adalimumab (160 mg): Treatment, Crohn's disease: Treatment.Disorder, adalimumab: Treatment.Drug, 160 mg: Treatment.Dosage, One week: Treatment.Time_elapsed) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  an acute exacerbation of Crohn's disease, the patient: Subject, fulminant cardiomyopathy: Effect, One week after the initial-dose of adalimumab (160 mg): Treatment, Crohn's disease: Treatment.Disorder, adalimumab: Treatment.Drug, 160 mg: Treatment.Dosage, One week: Treatment.Time_elapsed) 